aTyr Pharma Cash from Investing (TTM) Trends

aTyr Pharma Inc (LIFE)

1.70 -0.01 (-0.58%) USD | NASDAQ | May 10, 16:00

1.70 0.00 (0.00%) After-Hours: 20:00

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2014. Upgrade now.

Date	Value
March 31, 2024	16.69M
December 31, 2023	-20.13M
September 30, 2023	-35.95M
June 30, 2023	-19.68M
March 31, 2023	-5.553M
December 31, 2022	47.24M
September 30, 2022	-4.102M
June 30, 2022	-39.60M
March 31, 2022	-53.54M
December 31, 2021	-91.57M
September 30, 2021	-39.02M
June 30, 2021	-22.43M
March 31, 2021	-27.90M
December 31, 2020	6.90M
September 30, 2020	2.477M
June 30, 2020	7.946M
March 31, 2020	19.69M
December 31, 2019	4.925M
September 30, 2019	4.012M

Date	Value
June 30, 2019	17.53M
March 31, 2019	22.40M
December 31, 2018	37.17M
September 30, 2018	35.78M
June 30, 2018	-24.71M
March 31, 2018	-20.62M
December 31, 2017	-27.64M
September 30, 2017	-15.50M
June 30, 2017	30.94M
March 31, 2017	23.53M
December 31, 2016	33.53M
September 30, 2016	28.83M
June 30, 2016	29.38M
March 31, 2016	-59.43M
December 31, 2015	-71.99M
September 30, 2015	-73.15M
June 30, 2015	-79.74M
March 31, 2015	5.189M
December 31, 2014	-2.246M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-91.57M

Minimum

Dec 2021

47.24M

Maximum

Dec 2022

-11.60M

Average

-4.828M

Median

Cash from Investing (TTM) Benchmarks